Skip to content

Clinical trials

Phase 3 Urinary Bladder Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 3 Clear all

144 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20023
20042
20056
20077
20081
20094
20104
20112
20125
20132
20144
20155
20167
20173
20187
201910
20205
20219
20226
20238
20244
20256
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Active, not recruiting22
Unknown status20
Recruiting19
Terminated17
Withdrawn9
Not yet recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC7
Spectrum Pharmaceuticals, Inc6
Photocure5
Alliance for Clinical Trials in Oncology4
AstraZeneca4
European Organisation for Research and Treatment of Cancer - EORTC4
Memorial Sloan Kettering Cancer Center4
National Cancer Institute (NCI)4
SWOG Cancer Research Network4
UroGen Pharma Ltd.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms144
Non-Muscle Invasive Bladder Neoplasms23
Carcinoma, Transitional Cell19
Neoplasms14
Urologic Neoplasms9
Urethral Neoplasms7
Urinary Bladder Diseases6
Neoplasms by Site5
Prostatic Neoplasms5
Recurrence5

Trials

Showing 26 to 50 of 144. Each trial links to its page on Pharma Observatory.

44 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.